As the delta variant threatens to destabilize US economic activity via a possible 4th wave the leveraged loan pipeline has seen an uptick as issuers move to bring deals to market before Labor Day.
Over US$224bn of leveraged deals hit the pipeline in July, of which US$66.3bn was recorded in the last week of the month. The calendar includes US$7.8bn of secured and unsecured bridge loans that are part of the US$30bn LBO of Medline by private equity firms Blackstone, the Carlyle Group and Hellman & Friedman.
Meanwhile, over US$66bn of leveraged deal volume closed in July , up 62.3% from year ago levels, bringing 2021 leveraged loan volume to date to US$722bn, up 63% from US$442.4bn year over year. The shift in supply demand dynamics could precipitate a late summer shift in market sentiment in favor of investors on pricing and deal terms.
Latest news
European mid-market direct lending margins face steady compression since 2024
European mid-market direct lending margins have seen consistent compression over recent years but recorded a slight increase in the second quarter of 2026…
US leveraged loan issuance rebounds in September
Following three consecutive months of declining issuance, the US leveraged loan market has reversed course in September. Approximately $48.7b of…
Reversion to the Mean
Climbing toward the average is a very different story than surpassing it.